X-LINKED RETINITIS PIGMENTOSA
Clinical trials for X-LINKED RETINITIS PIGMENTOSA explained in plain language.
Never miss a new study
Get alerted when new X-LINKED RETINITIS PIGMENTOSA trials appear
Sign up with your email to follow new studies for X-LINKED RETINITIS PIGMENTOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy shows promise for rare eye disease
Disease control CompletedThis study tested a gene therapy (AAV5-RPGR) for people with X-linked retinitis pigmentosa, a genetic eye disease that causes vision loss. 105 participants received the treatment or a control. The main goal was to see if it improved their ability to navigate a maze after one year…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Gene therapy for rare blindness passes 5-Year safety check
Disease control CompletedThis study followed 42 people with X-linked retinitis pigmentosa, an inherited eye disease that causes vision loss, for up to 5 years after they received a gene therapy. The goal was to check the long-term safety of the treatment and see if it helped with functional vision, like …
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 12:05 UTC